GGrantIndex
Sort

1,049,261 grants matching t cell

Preclinical Development and Clinical Proof of Concept of a Synthetic Nanoparticle

$2,249,470
Lloyd Patrick Johnston · Selecta Biosciences, Inc. · U01 · FY2014 · DA

Validation of neuronal senescence as a target for chronic pain in aging

$2,249,392
Vivianne L Tawfik · Stanford University · RF1 · FY2024 · AG

Engineering Tregs for autoimmune diabetes therapy

$2,249,376
Brian T Fife · University Of Minnesota · R01 · FY2025 · DK

Flavivirus Infections: Pathogenesis and Prevention

$2,249,299
Alan L Rothman · University Of Rhode Island · P01 · FY2015 · AI

Ecopathogenomics of sexually transmitted infections (EPSTI)

$2,249,220
Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2017 · AI

Exosomes as mediators of cardiac injury and repair

$2,249,182
Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2021 · HL

Mechanisms of cardiovascular remodeling

$2,249,161
William S Harris · Sanford Research/Usd · P20 · FY2010 · RR

Stanford University Cancer Center

$2,249,153
Beverly Shriver Mitchell · Stanford University · P30 · FY2015 · CA

Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens

$2,249,057
Christopher Parks · International Aids Vaccine Initiative · P01 · FY2020 · AI

Flavivirus Infections: Pathogenesis and Prevention

$2,248,902
Alan L Rothman · University Of Rhode Island · P01 · FY2014 · AI

Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies

$2,248,840
Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Neural Crest Development and Disease

$2,248,791
Laura Kerosuo · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE

New potent orally bioavailable nitro-containing compounds to treat mycobacterial infections

$2,248,740
Robert B Abramovitch · Michigan State University · R01 · FY2025 · AI

LIVE-CELL, QUANTUM DOT-BASED TRACKING OF PLANT & MICROBIAL EXTRACELLULAR VESICLES

$2,248,719
University Of Delaware · · FY2019 · Department of Energy

Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.

$2,248,706
Gordon J Fishell · Broad Institute, Inc. · UG3 · FY2019 · MH

ADRC of the University of California, Irvine

$2,248,613
Frank M Laferla · University Of California-Irvine · P50 · FY2014 · AG

GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD

$2,248,581
Heather E Volk · Johns Hopkins University · R01 · FY2024 · ES

Targeting Causal Cancer Genes with Small Molecules

$2,248,488
Stuart L Schreiber · Broad Institute, Inc. · RC2 · FY2009 · CA

DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*

$2,248,455
Samson T Jacob · Ohio State University · P01 · FY2006 · CA

Development of Novel Therapeutic Strategies in Human Leukemias

$2,248,452
Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2017 · CA

VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION

$2,248,304
Dana-Farber Cancer Institute · P01 · FY2002 · AI

Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer

$2,248,301
William R Sellers · Dana-Farber Cancer Inst · P50 · FY2023 · CA

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

$2,248,270
James R Cerhan · Mayo Clinic Rochester · U01 · FY2017 · CA

Vascular Biology: Exercise Training and Vascular Disease

$2,248,258
M Harold Laughlin · University Of Missouri-Columbia · P01 · FY2008 · HL

Specialized Program of Research Excellence in Myeloma

$2,248,118
Dana-Farber Cancer Institute · P50 · FY2004 · CA